相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Myocardial fibrosis: biomedical research from bench to bedside
Mariann Gyoengyoesi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Saxagliptin and Tadalafil Differentially Alter Cyclic Guanosine Monophosphate (cGMP) Signaling and Left Ventricular Function in Aortic-Banded Mini-Swine
Jessica A. Hiemstra et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
Myocardial ATP hydrolysis rates in vivo: a porcine model of pressure overload-induced hypertrophy
Qiang Xiong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
A porcine model of hypertensive cardiomyopathy: implications for heart failure with preserved ejection fraction
Michael Schwarzl et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Left Ventricular Ejection Fraction (EF) of 55% as Cutoff for Late Transition From Heart Failure (HF) With Preserved EF to HF With Mildly Reduced EF
Tomoya Ueda et al.
CIRCULATION JOURNAL (2015)
Long-Term Effects of AAV1/SERCA2a Gene Transfer in Patients With Severe Heart Failure Analysis of Recurrent Cardiovascular Events and Mortality
Krisztina Zsebo et al.
CIRCULATION RESEARCH (2014)
Cardiac SERCA2A/B: Therapeutic targets for heart failure
Mohammad Abrar Shareef et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Circulating miR-29a, Among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients With Hypertrophic Cardiomyopathy
Roberta Roncarati et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
miRBase: annotating high confidence microRNAs using deep sequencing data
Ana Kozomara et al.
NUCLEIC ACIDS RESEARCH (2014)
Therapeutic Cardiac-Targeted Delivery of miR-1 Reverses Pressure Overload-Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling
Ioannis Karakikes et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Progressive induction of left ventricular pressure overload in a large animal model elicits myocardial remodeling and a unique matrix signature
William M. Yarbrough et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2012)
Is mitral E/E′ ratio a reliable predictor of left ventricular diastolic pressures in patients without heart failure?
Mario Previtali et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2012)
Epidemiology and risk profile of heart failure
Anh L. Bui et al.
NATURE REVIEWS CARDIOLOGY (2011)
Role of micro RNAs in cardiac hypertrophy, myocardial fibrosis and heart failure
De-li Dong et al.
ACTA PHARMACEUTICA SINICA B (2011)
Heart failure and mouse models
Ross Breckenridge
DISEASE MODELS & MECHANISMS (2010)
The role of inflammatory and fibrogenic pathways in heart failure associated with aging
Wei Chen et al.
HEART FAILURE REVIEWS (2010)
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Sharon Ann Hunt et al.
CIRCULATION (2009)
Small Animal Models of Heart Failure Development of Novel Therapies, Past and Present
Richard D. Patten et al.
CIRCULATION-HEART FAILURE (2009)
A model for left ventricular hypertrophy enabling non-invasive assessment of cardiac function
Soren Lunde et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL (2009)
Regulation of myocardial SERCA2a expression in ventricular hypertrophy and heart failure
Alice Muller et al.
FUTURE CARDIOLOGY (2005)
Hypertrophy of the heart - A new therapeutic target?
N Frey et al.
CIRCULATION (2004)
Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets
CL Andersen et al.
CANCER RESEARCH (2004)
Ventricular expression of natriuretic peptides in Npr1-/- mice with cardiac hypertrophy and fibrosis
LJ Ellmers et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
分享论文
